A Single-Arm, Open-Label, Prospective Study Evaluating the Safety, Tolerability, and Immunogenicity of the NeoOVIV Vaccine in Patients With Ovarian Cancer After Surgery

计划入组 9 人 · 首次发布于 2026 年 6 月 30 日

A Single-Arm, Open-Label, Prospective Study Evaluating the Safety, Tolerability, and Immunogenicity of the NeoOVSV Vaccine in Patients With Ovarian Cancer After Surgery

计划入组 9 人 · 首次发布于 2026 年 7 月 23 日

Study of CryptiVax-1001 in Maintenance Setting for Advanced Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

计划入组 50 人 · 首次发布于 2026 年 6 月 24 日

mRNA vaccine

mRNA-1608

mRNA therapeutic

Jaime Leandro Foundation for Therapeutic Cancer Vaccines

United States

AIM VACCINE

China

Travere Therapeutic

United States

WestGene's mRNA Cancer Vaccine WGc-043 Receives Dual IND Approvals for EBV-Related Cancers

Novel mRNA Cancer Vaccine Prevents Melanoma Recurrence in High-Risk Patients

Wu Yifang Appointed Chairman of Everest Medicines as Company Advances mRNA Cancer Vaccine Platform